Wednesday, 15 August 2018 - 9:57
  • it
  • de
  • en
  • fr

Adair

Disappointing 1st half from Hikma, shares drop 8.3%

Generics producer Hikma Pharmaceuticals today announced its 1st half 2017 financial results, which were far below analysts’ expectations. Hikma is experiencing the same issue as other generics manufacturers, such as Teva and Mylan, that is the loss of bargaining power…